Collectively, we firstly defined the oncogenic role of TMED3 in breast cancer showing that elevated TMED3 significantly correlated with inferior overall prognosis as well as ER, PR and HER2 status and that TMED3 can promote proliferation, migration and invasion of breast cancer cells in vitro. This evidence concerns the gene ESR1 and breast carcinoma.